KarXT Competitive Landscape & Market Strategy Project

As part of my work analyzing the emerging schizophrenia treatment space, I developed a comprehensive competitive landscape assessment for KarXT, a new therapy with a novel mechanism designed to reduce side effects associated with traditional antipsychotics. I evaluated unmet medical needs, patient pain points, and key barriers to adoption, then benchmarked KarXT against current standards of care and late-stage pipeline competitors.

My analysis included market sizing, revenue forecasting, and a full SWOT outlining clinical differentiation, safety profile advantages, and commercialization risks. I also explored pricing, reimbursement dynamics, and potential strategic positioning. This project strengthened my ability to translate clinical data into strategic insights and to evaluate how innovative therapies can create meaningful value in therapeutic landscapes.